InspireMD(NSPR) - 2025 Q2 - Quarterly Results

Exhibit 99.1 InspireMD Reports Second Quarter 2025 Financial Results --- Management to host investor conference call today, August 5, at 8:30am ET --- Miami, FL — August 5, 2025 – InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced financial and operating results for the second quarter and six months ended June 30, 2025. Recent Business Highlights: Marvin Slosman, CEO of InspireMD, commented: "Over the last few months, our team ha ...